Home/Filings/4/0001714899-24-000197
4//SEC Filing

Watts Ryan J. 4

Accession 0001714899-24-000197

CIK 0001714899other

Filed

Aug 21, 8:00 PM ET

Accepted

Aug 22, 4:16 PM ET

Size

5.8 KB

Accession

0001714899-24-000197

Insider Transaction Report

Form 4
Period: 2024-08-20
Watts Ryan J.
DirectorPresident and CEO
Transactions
  • Sale

    Common Stock

    2024-08-20$23.79/sh2,260$53,765235,807 total
Holdings
  • Common Stock

    (indirect: See footnote)
    2,202,604
Footnotes (3)
  • [F1]Shares sold to satisfy the tax obligations by the Reporting Person in connection with the settlement of previously vested restricted stock units.
  • [F2]Includes 197,200 Unvested RSUs.
  • [F3]The shares are held of record by the Watts Family 2015 Trust dated July 7, 2015, for which the Reporting Person serves as trustee.

Issuer

Denali Therapeutics Inc.

CIK 0001714899

Entity typeother

Related Parties

1
  • filerCIK 0001724310

Filing Metadata

Form type
4
Filed
Aug 21, 8:00 PM ET
Accepted
Aug 22, 4:16 PM ET
Size
5.8 KB